B-cell lymphoma response to anti-CD20 antibodies based therapies is tightly modulated by FOXO1 mediated MS4A1 gene transcription.
Authors: Zerrouqi A., Pyrzynska B., Dwojak M., Miazek N., Zapala P., Golab J., Winiarska M.
Published in: AACR Special Conference on Tumor Immunology and Immunotherapy
Publication type: conference